Radiation-induced morphea: Association with autoimmune comorbidities, severity, and response to therapy

J Am Acad Dermatol. 2019 Jul;81(1):260-262. doi: 10.1016/j.jaad.2019.02.039. Epub 2019 Feb 21.

Authors

Amit Mittal¹, Vaishali Mittal², Gauri Panse¹, Jennifer N Choi³, Bernice Y Kwong², Jonathan S Leventhal⁴

Affiliations

¹ Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
² Department of Dermatology, Stanford University School of Medicine, Stanford, California.
³ Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
⁴ Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: [email protected].

PMID: 30797843
DOI: 10.1016/j.jaad.2019.02.039

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Academic Medical Centers
Adult
Aged
Autoimmune Diseases / diagnosis
Autoimmune Diseases / epidemiology*
Breast Neoplasms / mortality
Breast Neoplasms / radiotherapy*
Breast Neoplasms / surgery
Combined Modality Therapy
Comorbidity
Connecticut
Disease-Free Survival
Female
Humans
Incidence
Mastectomy / methods
Middle Aged
Prognosis
Radiotherapy Dosage
Radiotherapy, Adjuvant / adverse effects
Risk Assessment
Scleroderma, Localized / etiology*
Scleroderma, Localized / physiopathology
Scleroderma, Localized / therapy
Survival Analysis